companydata.dkcompanydata.dk

AJ Vaccines A/S: Financial statements 2020

CVR: 37911143

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 351,618,000 and a net result of DKK -450,212,000 compared with DKK -288,603,000 the year before. That is an increase of 8.7% compared with the year before. The profit margin was -128%. Equity in the 2020 report amounted to DKK 1,052,358,000. The solvency ratio was 60.9%. The company had 702 employees in the financial year.

Revenue
DKK 351,618,000
Gross Profit
DKK -313,896,000
Profit/Loss
DKK -450,212,000
Equity
DKK 1,052,358,000
Total Assets
DKK 1,727,645,000
Employees
702

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020351.6M-313.9M-450.2M1.1B702
2019323.5M-224.5M-288.6M1.2B719
2018362.2M-150.7M-244.5M903.2M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is AJ Vaccines A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

AJ Vaccines A/S: The 2019 annual report is outSep 4, 2020

AJ Vaccines A/S has published its annual report for 2019. Revenue came to DKK 323,471,000, and the net result was DKK -288,603,000.

Shan-E-Abbas Ashary joins the board of AJ Vaccines A/SMay 28, 2020

As of May 28, 2020, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.

Abdul Wahab Mohammed A Alesayi joins the board of AJ Vaccines A/SMay 28, 2020

As of May 28, 2020, Abdul Wahab Mohammed A Alesayi has joined the board of directors of AJ Vaccines A/S.

Saddam Abdulqawi Hussein Alhumaikani joins the board of AJ Vaccines A/SMay 28, 2020

As of May 28, 2020, Saddam Abdulqawi Hussein Alhumaikani has joined the board of directors of AJ Vaccines A/S.

Jesper Helmuth Larsen leaves the board of AJ Vaccines A/SMay 28, 2020

As of May 28, 2020, Jesper Helmuth Larsen has left the board of directors of AJ Vaccines A/S.

Saddam Abdulqawi Hussein Alhumaikani leaves the board of AJ Vaccines A/SMar 23, 2020

As of March 23, 2020, Saddam Abdulqawi Hussein Alhumaikani has left the board of directors of AJ Vaccines A/S.

About AJ Vaccines A/S

AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.

Source: annual report 2025, Danish Business Authority

Other financial years